- •Patients with surgically excised B3 lesions do not benefit from clinical surveillance.
- •Clinicians should consider other factors when deciding length of follow-up.
- •Subsequent development of invasive cancers in surgically excised B3 lesions remains rare.
Patients and Methods
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
- Radial scars diagnosed on breast core biopsy: frequency of atypia and carcinoma on excision and implications for management.The Breast. 2016; 30: 201-207
- Positive predictive value for malignancy on surgical excision of breast lesions of uncertain malignant potential (B3) diagnosed by stereotactic vacuum-assisted needle core biopsy (VANCB): a large multi-institutional study in Italy.Breast. 2011; 20: 264-270
- Image-guided breast biopsy: state-of-the-art.Clin Radiol. 2010; 65: 259-270
- A new risk stratification score for the management of ultrasound-detected B3 breast lesions.Breast J. 2018; 24: 965-970
- Underestimation of malignancy of breast core-needle biopsy: concepts and precise overall and category-specific estimates.Cancer. 2007; 109: 487-495
- Long term clinical follow-up of atypical ductal hyperplasia and lobular carcinoma in situ in breast core needle biopsies.Pathology. 2016; 48: 25-29
- NHS breast screening programme clinical guidance for breast cancer screening assessment: NHSBSP publication number 49.4th edition. Public Health England, London, England2016
- First international consensus conference on lesions of uncertain malignant potential in the breast (B3 lesions).Breast Cancer Res Treat. 2016; 159: 203-213
- Second international consensus conference on lesions of uncertain malignant potential in the breast (B3 lesions).Breast Cancer Res Treat. 2019; 174: 279-296
- Upgrade of high-risk breast lesions detected on mammography in the Breast Cancer Surveillance Consortium.Am J Surg. 2014; 207: 24-31
- Consensus guideline on concordance assessment of image guided breast biopsies and management of borderline or high risk lesions. Official statement.4th edition. American Society of Breast Surgeons Columbia, MD2016
- Radial scars and complex sclerosing lesions on core needle biopsy of the breast: upgrade rates and long-term outcomes.Breast Cancer Res Treat. 2020; 183: 677-682
- WHO Classification of Tumours Editorial Board. The 2019 World Health Organization classification of tumours of the breast.Histopathology. 2020; 77: 181-185https://doi.org/10.1111/his.14091
- Cost-effectiveness and benefit-to-harm ratio of risk-stratified screening for breast cancer: a life-table model.JAMA Oncol. 2018; 4: 1504-1510
- Clinical and radiologic follow-up study for biopsy diagnosis of radial scar/radial sclerosing lesion without other atypia.Breast J. 2016; 22: 637-644
- Benign breast disease and the risk of breast cancer.N Engl J Med. 2005; 353: 229-237
- Report of the working party for higher- risk breast screening.2nd Edition. Public Health England, London2015
- Correlation between core biopsy and excisional biopsy in breast high-risk lesions.Am J Surg. 2006; 192: 534-537
- Stratification of breast cancer risk in women with atypia: a Mayo cohort study.J Clin Oncol. 2007; 25: 2671-2677
- Magnitude and laterality of breast cancer risk according to histologic type of atypical hyperplasia: results from the Nurses' Health Study.Cancer. 2007; 109: 180-187
- Bilateral risk for subsequent breast cancer after lobular carcinoma-in-situ: analysis of surveillance, epidemiology, and end results data.J Clin Oncol. 2005; 23: 5534-5541
- Pathologic findings from the national surgical adjuvant breast and bowel project: twelve-year observations concerning lobular carcinoma in situ.Cancer. 2004; 100: 238-244
Accessed from: https://www.gov.uk/guidance/breast-screening-the-sloane-project. Accessed date: July 2nd 2021.